Skip to main content
AppaltiWatch

NEUPHARMA S.R.L.

Risk signal — not an accusation of crime.
—77

This supplier won 25 flagged tenders from 17 different contracting authorities; 44% had low competition — worth reviewing.

Flagged wins

25

of 359 total awards

Distinct contracting authorities

17

Rotation index 0.68

Low competition

44%

11 tenders with one bidder

Flagged spend

€5,062,042

Most frequent signals
Rules that fire most often on this entity's flagged tenders.
  • stalled_execution23
  • missing_funding_source20
  • repeat_supplier18
  • direct_award18
  • short_submission_window17
  • single_bidder11
  • direct_award_over_threshold4
  • short_decision_period3
Trend (12 months)
Flagged tenders per month — last 12 months with data in the loaded dataset.
Linked contracting authorities
Authorities this supplier won flagged tenders from.
Tenders to review
Sorted by score — open detail to see what to verify.
See all tendersView supplier–authority rotation

Keep investigating

Aggregate statistics on ANAC data — not an accusation of crime.

Risk signal — not an accusation of crime.
NEUPHARMA S.R.L. — AppaltiWatch